MR Microinsurance_2012_03_29.indd - International Labour ...
MR Microinsurance_2012_03_29.indd - International Labour ... MR Microinsurance_2012_03_29.indd - International Labour ...
148 Health insurance Box 6.6 Monitoring the service quality of health care Zurich Bolivia and BancoSol have a TPP mechanism in place with a third-party administrator (TPA), PROVID. PROVID receives a capitation payment (and then pays contracted healthcare providers according to various methods of pay- ment including fee-for-service). PROVID monitors utilization of health services and maintains claims data. It also performs regular spot checks of service quality in contracted health facilities by sending its staff to pose as potential patients to test how they are received and treated. Because BancoSol distributes the HMI product to its microfi nance clients, comment boxes have been placed in BancoSol branches to allow insured clients to comment on the HMI services. It is critical for the microfi nance institution to make sure that clients are satisfi ed with the HMI scheme as it may aff ect BancoSol’s reputation. Source: Authors. HMI schemes can evaluate the frequency and type of healthcare services being delivered to individual patients, or by specifi c healthcare providers. Th e evaluator (ideally a clinical professional from the HMI scheme) can meet healthcare providers to discuss unusual cases and trends, and develop appropriate interventions. Setting standards for quality In all seven case studies, the contracts for healthcare providers establish standards for various aspects of quality. For example, contracts often require that insured patients be treated in the same way as non-insured patients in terms of access to services and clinical standards of treatment. Th e behaviour of healthcare providers towards HMI scheme members should be monitored for any evidence that members receive inferior service. Th is can occur because of a perception that a patient not paying cash out-of-pocket at the time the service is provided, or who is receiving discounts or special rates, is socio-economically inferior. Some contracts under TPP mechanisms stipulate adherence to treatment protocols or care guidelines, and ensure availability of essential drugs. In other contracts, such as that of UMSGF (see Box 6.7), healthcare providers are prohibited from requesting additional fees beyond those laid down in the plan of benefi ts, such as co-payments. Such provisions exist to discourage fraudulent practices, which can be rampant in facilities where salaries are low or a culture of corruption prevails. For some HMI schemes, a performance-based contract may be a useful way of promoting quality of care. GRET-SKY is testing a performance-based contract
Th ird-party payment mechanisms in health microinsurance with a capitation payment adjusted by utilization rates. Targets for utilization of services are set with each provider and a capitation payment is associated with this target. If the actual utilization is below target, providers receive a decreased capitation payment. When utilization exceeds the target, healthcare providers also receive a decreased capitation payment, but to a lesser extent. Th e objective is to encourage health providers to achieve an optimum (desirable) utilization, and to discourage potential over-utilization. Th e use of utilization as an indirect indicator of clinical quality can be useful in a context where more specifi c measures of clinical quality may be unavailable. Box 6.7 Improving quality of care Despite collaborative relationships with healthcare providers, quality of care is a core challenge for UMSGF. Th e HMI scheme has taken a number of measures to improve the situation. Contracted health facilities are under-fi nanced and face signifi cant drug short- short- ages. To improve the quality of care (and client satisfaction), UMSGF began to cover the cost of drugs purchased in private pharmacies when prescribed by a con- tracted hospital. Unfortunately, this initiative resulted in a rapid rise in claims costs and thus had to be stopped. Now, a revolving fund for drugs has been set up with donor support to purchase a stock of drugs that can be provided to clients when a prescription is not available directly from a contracted provider. Additionally, fi nancial incentives have been set up to encourage medical staff to provide appropriate care to insured patients and limit unauthorized payments by patients (e.g. bribes for drugs). More recently, a liaison offi cer was assigned to each contracted facility to ensure that insured patients are appropriately wel- comed and served. Source: Authors. Promoting clinical quality through medical advisers Related to clinical quality, cases studies show that medical advisers can play a key role in measuring quality of care against defi ned standards, especially when a healthcare provider is not directly involved in claims and care management (FMiA, UMSGF, GRET-SKY, CBHI). A medical adviser monitors quality of care with healthcare providers through the following main functions: – Assessing whether insured patients receive appropriate healthcare services according to diagnosis and health status. Th is assessment can be either 1) prospective, when authorizing treatment or assessing a provider against network participa- 149
- Page 119 and 120: Microinsurance and climate change B
- Page 121 and 122: Microinsurance and climate change C
- Page 123 and 124: Microinsurance and climate change -
- Page 125 and 126: Microinsurance and climate change -
- Page 127 and 128: Microinsurance and climate change -
- Page 129 and 130: Microinsurance and climate change 1
- Page 131 and 132: Microinsurance and climate change 4
- Page 133 and 134: II Health insurance
- Page 135 and 136: Innovations and barriers in health
- Page 137 and 138: Innovations and barriers in health
- Page 139 and 140: Innovations and barriers in health
- Page 141 and 142: Innovations and barriers in health
- Page 143 and 144: Innovations and barriers in health
- Page 145 and 146: Innovations and barriers in health
- Page 147 and 148: Innovations and barriers in health
- Page 149 and 150: Innovations and barriers in health
- Page 151 and 152: Innovations and barriers in health
- Page 153 and 154: Innovations and barriers in health
- Page 155 and 156: Th ird-party payment mechanisms in
- Page 157 and 158: Th ird-party payment mechanisms in
- Page 159 and 160: Th ird-party payment mechanisms in
- Page 161 and 162: Third-party payment mechanisms in h
- Page 163 and 164: Th ird-party payment mechanisms in
- Page 165 and 166: Th ird-party payment mechanisms in
- Page 167 and 168: Th ird-party payment mechanisms in
- Page 169: Third-party payment mechanisms in h
- Page 173 and 174: Third-party payment mechanisms in h
- Page 175 and 176: Th ird-party payment mechanisms in
- Page 177 and 178: Third-party payment mechanisms in h
- Page 179 and 180: Willingness to pay for health micro
- Page 181 and 182: Willingness to pay for health micro
- Page 183 and 184: Willingness to pay for health micro
- Page 185 and 186: Willingness to pay for health micro
- Page 187 and 188: Willingness to pay for health micro
- Page 189 and 190: Willingness to pay for health micro
- Page 191 and 192: Willingness to pay for health micro
- Page 193 and 194: Willingness to pay for health micro
- Page 195: Willingness to pay for health micro
- Page 198 and 199: 176 8 Savings in microinsurance: Le
- Page 200 and 201: 178 Life insurance - Understanding
- Page 202 and 203: 180 Life insurance Finally, the stu
- Page 204 and 205: 182 Life insurance Max Vijay offere
- Page 206 and 207: 184 Life insurance 8.2.3 SBI Life
- Page 208 and 209: 186 Life insurance - Reward for pre
- Page 210 and 211: 188 Life insurance capacity, and co
- Page 212 and 213: 190 Life insurance and administrati
- Page 214 and 215: 192 Life insurance 2. A surrender t
- Page 216 and 217: 194 Life insurance be earned from o
- Page 218 and 219: 196 Life insurance four of them), p
148 Health insurance<br />
Box 6.6 Monitoring the service quality of health care<br />
Zurich Bolivia and BancoSol have a TPP mechanism in place with a third-party<br />
administrator (TPA), PROVID. PROVID receives a capitation payment (and<br />
then pays contracted healthcare providers according to various methods of pay-<br />
ment including fee-for-service). PROVID monitors utilization of health services<br />
and maintains claims data. It also performs regular spot checks of service quality<br />
in contracted health facilities by sending its staff to pose as potential patients to<br />
test how they are received and treated.<br />
Because BancoSol distributes the HMI product to its microfi nance clients,<br />
comment boxes have been placed in BancoSol branches to allow insured clients<br />
to comment on the HMI services. It is critical for the microfi nance institution to<br />
make sure that clients are satisfi ed with the HMI scheme as it may aff ect<br />
BancoSol’s reputation.<br />
Source: Authors.<br />
HMI schemes can evaluate the frequency and type of healthcare services being<br />
delivered to individual patients, or by specifi c healthcare providers. Th e evaluator<br />
(ideally a clinical professional from the HMI scheme) can meet healthcare providers<br />
to discuss unusual cases and trends, and develop appropriate interventions.<br />
Setting standards for quality<br />
In all seven case studies, the contracts for healthcare providers establish standards<br />
for various aspects of quality. For example, contracts often require that insured<br />
patients be treated in the same way as non-insured patients in terms of access to<br />
services and clinical standards of treatment. Th e behaviour of healthcare providers<br />
towards HMI scheme members should be monitored for any evidence that<br />
members receive inferior service. Th is can occur because of a perception that a<br />
patient not paying cash out-of-pocket at the time the service is provided, or who<br />
is receiving discounts or special rates, is socio-economically inferior. Some contracts<br />
under TPP mechanisms stipulate adherence to treatment protocols or care<br />
guidelines, and ensure availability of essential drugs.<br />
In other contracts, such as that of UMSGF (see Box 6.7), healthcare providers<br />
are prohibited from requesting additional fees beyond those laid down in the<br />
plan of benefi ts, such as co-payments. Such provisions exist to discourage<br />
fraudulent practices, which can be rampant in facilities where salaries are low or a<br />
culture of corruption prevails.<br />
For some HMI schemes, a performance-based contract may be a useful way<br />
of promoting quality of care. GRET-SKY is testing a performance-based contract